NasdaqGM - Delayed Quote USD

Artiva Biotherapeutics, Inc. (ARTV)

11.19 +0.06 (+0.58%)

At close: September 4 at 4:00:01 PM EDT

11.30 +0.11 (+0.98%)

After hours: September 4 at 7:45:27 PM EDT

Trade ARTV on Coinbase

Loading Chart for ARTV

Chart Range Bar

Interval:

In partnership with ChartIQ

Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in September

Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Artiva Biotherapeutics Announces Pricing of $300 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Artiva Biotherapeutics Spotlights RA as Lead NK Cell Program, Eyes H1 Efficacy Data Catalyst at Needham

Wedbush Predicts Up to ~600% Jump for These 2 ‘Strong Buy’ Stocks

$Artiva Biotherapeutics Highlights AlloNK® Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today$

Artiva Biotherapeutics Highlights AlloNK® Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today

Artiva Biotherapeutics Appoints Veteran Biotech Executive and Drug Developer Diego Miralles, M.D., as President and Head of Research and Development

Is Artiva Biotherapeutics (NASDAQ:ARTV) In A Good Position To Deliver On Growth Plans?

Artiva Biotherapeutics to Participate in the 2026 Jefferies Global Healthcare Conference

$Artiva Biotherapeutics (ARTV): Valuation Snapshot Following FDA Fast Track for AlloNK in Refractory Rheumatoid Arthritis$

Artiva Biotherapeutics (ARTV): Valuation Snapshot Following FDA Fast Track for AlloNK in Refractory Rheumatoid Arthritis

Artiva Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights

RCKT

KYTX

CGON

ABOS

HOWL

ANRO

FOLD

RAPP

ACRV

SABS

Yahoo Finance

U.S. markets closed